GlassScriptPhysician profile
Elizabeth Rowan
NPI 1417385428
$413.97
in general payments reported to CMS, 2019-2025
13 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $140 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $85.76 | 2024 | Inspire |
| Boston Scientific Corporation | $49.04 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Edwards Lifesciences Corporation | $42.87 | 2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Exact Sciences Corporation | $40.97 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $31.66 | 2025 | Otezla, Repatha |
| Takeda Pharmaceuticals U.S.A., INC. | $25.90 | 2025 | Trintellix |
| Xeris Pharmaceuticals, INC. | $22.59 | 2025 | Gvoke Hypopen |
| Abbvie INC. | $22.26 | 2025 | |
| Sanofi Pasteur INC. | $21.58 | 2025 | |
| Dexcom, INC. | $18.55 | 2025 | Dexcom G6 Transmitter |
| Hologic Sales and Service, LLC | $18.52 | 2025 | Thinprep 2000 Processor, Aptima |
| Astrazeneca Pharmaceuticals LP | $17.47 | 2025 | |
| Glaxosmithkline, LLC. | $16.80 | 2025 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Rowan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.